Open Access
Issue |
BIO Web Conf.
Volume 100, 2024
International Scientific Forum “Modern Trends in Sustainable Development of Biological Sciences” (IFBioScFU 2024)
|
|
---|---|---|
Article Number | 01013 | |
Number of page(s) | 6 | |
Section | Interdisciplinary Research in Biophysics, Biomedicine, and Neuroscience | |
DOI | https://doi.org/10.1051/bioconf/202410001013 | |
Published online | 08 April 2024 |
- J. Ferlay. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 136(5):359–386 (2015) https://doi.org/10.1002/ijc.29210 [Google Scholar]
- A. Raza, G.K. Sood. Hepatocellular carcinoma review: Current treatment, and evidencebased medicine. 4115–4127 (2014) https://dx.doi.org/10.3748/wjg.v20.i15.4115 [Google Scholar]
- M.A. Geller. Use of allogeneic NK cells for cancer immunotherapy. Immunotherapy 3, 1445–1459 (2011) https://doi.org/10.3390/cancers11060769 [CrossRef] [Google Scholar]
- E. Vivier. Functions of natural killer cells. Nat Immunol. 9, 503–510 (2008) https://doi.org/10.1038/ni1582 [CrossRef] [PubMed] [Google Scholar]
- E. Lusty, M. Sophie, K. Kwofie, T.S. Mandur, D.C. Richards, A.A. Ashkar. IL-18/IL-15/IL-12 synergy induces elevated and prolonged IFN-y production by ex vivo expanded NK cells which is not due to enhanced STAT4 activation. 138–147 (2017) https://doi.org/10.1016/j.molimm.2017.06.025 [Google Scholar]
- E. Vivier, E. Tomasello, M. Baratin, T. Walzer, S. Ugolini. Functions of natural killer cells (2008) https://doi.org/10.1038/ni1582 [Google Scholar]
- J. Rajkovic, R. Novakovic, J. Grujic-Milanovic, A. Ydyrys, N. Ablaikhanova, D. Calina, J. Sharifi-Rad, B. Al-Omari. An updated pharmacological insight into calotropin as a potential therapeutic agent in cancer //Front Pharmacol., 14, 1–12 (2023) https://doi.org/10.3389%2Ffphar.2023.1160616 [Google Scholar]
- A.R. Khaled. Lymphocide: cytokines and the control of lymphoid homeostasis. Nat Rev Immunol 2 (11) (2002), 817–830. https://doi.org/10.1038/nri931 [CrossRef] [PubMed] [Google Scholar]
- A. Marcais. Regulation of mouse NK cell development and function by cytokines Front Immunol 4, 450 (2013) https://doi.org/10.3389/fimmu.2013.00450 [Google Scholar]
- V. Male. Transcriptional control of NK cell differentiation and function. Curr Top Microbiol Immunol 381:173–187 (2014) https://doi.org/10.1007/82_2014_376 [PubMed] [Google Scholar]
- M.D. Boos. Extrinsic and intrinsic regulation of early NK cells development. Immunol Res 40(3):193–207 (2008) https://doi.org/10.1007/s12026-007-8006-9 [CrossRef] [Google Scholar]
- C.M. Sawai. Hematopoietic stem cells are the major source of multilineage hematopoiesis in adult animals. Immunity 45 (3), 597–609 (2016) https://doi.org/10.1016/j.immuni.2016.08.007 [CrossRef] [Google Scholar]
- A. Ota, M. Tajima, K. Mori, E. Sugiyama, V.H. Sato, H. Sato. The selective cytotoxicity of silver thiosulfate, a silver complex, on MCF-7 breast cancer cells through ROS-induced cell death. Pharmacol Rep. Jun; 73(3), 847–857 (2021) https://doi.org/10.1007/s43440-021-00260-0 [CrossRef] [PubMed] [Google Scholar]
- P. Zhang, G. Zhang, X. Wan. Challenges and new technologies in adoptive cell therapy. J Hematol Oncol 16, 97 (2023) https://doi.org/10.1186/s13045-023-01492-8 [CrossRef] [PubMed] [Google Scholar]
- L. Quatrini, D. Chiesa, S. Sivori, M.C. Mingari, D. Pende, L. Moretta. Human NK cells, their receptors and function. Eur. J. Immunol., 51: 1566–1579 (2021) https://doi.org/10.1002/eji.202049028 [CrossRef] [PubMed] [Google Scholar]
- M. Doskali, Y. Tanaka, M. Ohira, K. Ishiyama, H. Tashiro, K. Chayama, H. Ohdan. Possibility of adoptive immunotherapy with peripheral blood-derived CD3 CD56+ and CD3+CD56+ cells for inducing antihepatocellular carcinoma and antihepatitis C virus activity. J Immunother Mar, 34 (2), 129–138 (2011) https://doi.org/10.1097/cji.0b013e3182048c4e [CrossRef] [PubMed] [Google Scholar]
- L.B. Sullivan, N.S. Chandel. Mitochondrial reactive oxygen species and cancer. Cancer Metab 2 (17) (2014) https://doi.org/10.1186%2F2049-3002-2-17 [CrossRef] [Google Scholar]
- J.A. Marrero. Current Treatment Approaches in HCC. Clin Adv Hematol Oncol. 11 Suppl 5:15–18 (2013) https://doi.org/10.21037%2Fjgo.2020.02.08 [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.